GSK3B and Alzheimer disease: These outcomes might depend on the p-AKT (ser473)/p-GSK3β (ser9) signaling pathway activated by hDPSCs upregulates the expression of Nrf2, as well as its target genes such as HO-1, thus exerts neuroprotective efficacy in the hippocampus against the progressive AD pathology.